April 26, 2007
Drug company pays $2.9 million to Mass. to settle price reporting litigation
California-based Dey, Inc., a manufacturer of generic pharmaceuticals, has paid the Commonwealth of Massachusetts $2.9 million to settle litigation pending in the Federal District Court in Boston. Massachusetts...
Posted In Whistleblower Law Insights
U.S. joins qui tam suit against HealthEssentials Solutions
The U.S. Dept. of Justice announced on April 26, 2007 that it has intervened in three qui tam suits accusing HealthEssentials Solutions Inc. (HES) of false claims billings to Medicare. HES is accused of...
Posted In Whistleblower Law Insights
Supreme Court will not review U. of Phoenix FCA suit
The U.S. Supreme Court has declined to hear an appeal by the University of Phoenix from a decision by the Ninth Circuit. That decision (as reported here on September 8, 2006) reinstated a suit brought...
Posted In Whistleblower Law Insights
California hospital settles qui tam suit for over $2 million
Loma Linda Behavioral Medicine Center has paid the government more than $2 million to settle allegations that it fraudulently overbilled Medicare and Medi-Cal, the state Medicaid program. The suit originated...
Posted In Whistleblower Law Insights
Senate report says drug companies use continuing medical education grants to influence doctors
The Finance Committee of the U.S. Senate issued a report on April 25, 2007 on pharmaceutical manufacturers’ use of educational grants. The press release from Committee Chairman Max Baucus says that...
Posted In Whistleblower Law Insights
California hospital pays $2 million to settle whistleblower’s Medicare fraud case
LOS ANGELES, CA – The Loma Linda Behavioral Medicine Center has paid the federal government more than $2 million to settle a whistleblower case, brought by Phillips & Cohen, that alleged the Redlands,...
Posted In Phillips & Cohen News
April 19, 2007
US intervenes in suits against Hewlett-Packard, Accenture and Sun Microsystems
The United States Dept. of Justice announced that it has intervened in three whistleblower suits alleging that Hewlett-Packard, Accenture LLP, and Sun Microsystems Inc. violated the False Claims Act. The...
Posted In Whistleblower Law Insights
Medicare fraud costs billions each year
The acting head of Medicare told a congressional subcommittee that Medicare fraud costs billions of dollars each year. Leslie Norwalk said, “The fraudulent business practices of unscrupulous durable...
Posted In Whistleblower Law Insights
Cell Therapeutics to settle qui tam suit
Cell Therapeutics, a Seattle-based biotech start-up, has agreed to pay $10.5 million to settle charges that it illegally marketed the anti-cancer prescription drug Trisonex for uses that had not received...
Posted In Whistleblower Law Insights
April 17, 2007
Georgia Senate passes Medicaid FCA
The Georgia Senate has passed HB 551, the State Medicaid False Claims Act. The bill, introduced by Rep. Edward Lindsey of Atlanta, had already been passed by the Georgia House. If it is enacted, Georgia...
Posted In Whistleblower Law Insights